Turn Therapeutics (TTRX) Non-Current Deffered Revenue (2024 - 2026)

Turn Therapeutics' Non-Current Deffered Revenue history runs 3 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• In Q1 2026, Non-Current Deffered Revenue changed N/A year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (changed N/A YoY), while the FY2025 annual figure was $1.4 million, changed 0.0% from the prior year.
• Non-Current Deffered Revenue was $1.4 million for Q1 2026 at Turn Therapeutics, roughly flat from $1.4 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $1.4 million in Q4 2024 to a low of $1.4 million in Q4 2024.
• Historically, Non-Current Deffered Revenue has averaged $1.4 million across 3 years, with a median of $1.4 million in 2024.
• Biggest YoY gain for Non-Current Deffered Revenue was 0.0% in 2025; the steepest drop was 0.0% in 2025.
• A 3-year view of Non-Current Deffered Revenue shows it stood at $1.4 million in 2024, then changed by 0.0% to $1.4 million in 2025, then changed by 0.0% to $1.4 million in 2026.
• The last three Non-Current Deffered Revenue figures came in at $1.4 million (Q1 2026), $1.4 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.